Shares of IperionX Limited Sponsored ADR (NASDAQ:IPX - Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $21.47, but opened at $20.38. IperionX shares last traded at $19.98, with a volume of 39,048 shares trading hands.
Analyst Ratings Changes
Several equities research analysts recently issued reports on IPX shares. BTIG Research raised their target price on shares of IperionX from $40.00 to $55.00 and gave the company a "buy" rating in a research note on Friday, June 5th. Jefferies Financial Group initiated coverage on shares of IperionX in a research report on Wednesday, September 2nd. They set a "buy" rating and a $26.00 price objective for the company. Roth Capital set a $53.00 price target on IperionX in a research note on Wednesday, August 5th. Finally, Weiss Ratings reiterated a "sell (e+)" rating on shares of IperionX in a research note on Friday, July 17th. Six investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, IperionX has a consensus rating of "Moderate Buy" and a consensus price target of $46.50.
Get Our Latest Research Report on IperionX
IperionX Price Performance
The company has a 50 day simple moving average of $22.09 and a 200 day simple moving average of $29.07. The company has a debt-to-equity ratio of 0.03, a quick ratio of 4.00 and a current ratio of 4.03.
Insider Activity at IperionX
In other IperionX news, CEO Anastasios Arima purchased 138,720 shares of the firm's stock in a transaction on Friday, July 10th. The stock was purchased at an average cost of $3.58 per share, for a total transaction of $496,617.60. Following the transaction, the chief executive officer owned 12,455,502 shares in the company, valued at $44,590,697.16. The trade was a 1.13% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Chairman Todd Hannigan bought 300,000 shares of the business's stock in a transaction on Monday, July 13th. The shares were bought at an average cost of $3.59 per share, for a total transaction of $1,077,000.00. Following the completion of the acquisition, the chairman directly owned 26,633,334 shares in the company, valued at approximately $95,613,669.06. This trade represents a 1.14% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last quarter, insiders have purchased 663,720 shares of company stock worth $2,379,118.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the company. Connective Capital Management LLC bought a new stake in IperionX during the 2nd quarter valued at $160,000. GAMMA Investing LLC lifted its stake in IperionX by 40.3% during the 2nd quarter. GAMMA Investing LLC now owns 1,681 shares of the company's stock valued at $50,000 after acquiring an additional 483 shares in the last quarter. DLD Asset Management LP purchased a new stake in shares of IperionX in the first quarter valued at about $260,000. Private Advisor Group LLC lifted its position in shares of IperionX by 69.9% during the 1st quarter. Private Advisor Group LLC now owns 63,111 shares of the company's stock worth $1,643,000 after buying an additional 25,964 shares in the last quarter. Finally, Corigliano Investment Advisers LLC bought a new stake in IperionX during the fourth quarter worth $362,000. 2.76% of the stock is owned by institutional investors and hedge funds.
About IperionX
(
Get Free Report)
IperionX Limited NASDAQ: IPX is a materials technology company focused on developing a low-carbon, fully integrated titanium supply chain in the United States. The company is working to produce titanium metal and titanium products from locally sourced mineral resources, with applications across the aerospace, defense, automotive, medical and consumer industries.
IperionX's flagship asset is the Titan Project in Tennessee, which contains titanium, rare earth and zircon-rich mineral sands.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider IperionX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IperionX wasn't on the list.
While IperionX currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.